Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial-Reference-Cited by-同舟云学术

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial

Published:2013-07 Issue:8 Volume:14 Page:749-759
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Seymour Matthew T,Brown Sarah R,Middleton Gary,Maughan Timothy,Richman Susan,Gwyther Stephen,Lowe Catherine,Seligmann Jennifer F,Wadsley Jonathan,Maisey Nick,Chau Ian,Hill Mark,Dawson Lesley,Falk Stephen,O'Callaghan Ann,Benstead Kim,Chambers Philip,Oliver Alfred,Marshall Helen,Napp Vicky,Quirke Phil

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer;Amado;J Clin Oncol,2008

2. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status;Van Cutsem;J Clin Oncol,2011

3. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study;Bokemeyer;Annals Oncol,2011

4. Ciclosporin in combination with irinotecan for chemoresistant advanced colorectal cancer: results of PICCOLO, a large randomised trial with prospective molecular stratification;Middleton;Eur J Cancer,2011

5. New guidelines to evaluate the response to treatment in solid tumors;Therasse;J Natl Cancer Inst,2000

Cited by 324 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review;Cancers;2024-08-08

2. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-06

3. Impact of Systemic Treatments on Outcomes and Quality of Life in Patients with RAS-Positive Stage IV Colorectal Cancer: A Systematic Review;Diseases;2024-04-20

4. Deciphering the functional landscape and therapeutic implications of noncoding RNAs in the TGF-β signaling pathway in colorectal cancer: A comprehensive review;Pathology - Research and Practice;2024-03

5. Predictive and prognostic biomarkers in gastrointestinal tract tumours;Pathology;2024-03